• OPEN AN ACCOUNT
Indian Indices
Sensex
76,909.68 -325.78
( -0.42%)
Global Indices
Nasdaq
53,360.44 -120.34
(-0.23%)
Dow Jones
7,713.14 -52.92
(-0.68%)
Hang Seng
65,335.94 -2,124.79
(-3.15%)
Nikkei 225
10,747.45 19.41
(0.18%)
Forex
USD-INR
95.60 0.07
(0.07%)
EUR-INR
110.76 0.24
(0.21%)
GBP-INR
129.56 0.29
(0.22%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Transgene Biotek Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
526139
INE773D01018
-1.2142009
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
21.59
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Devyani International reports consolidated net loss of Rs 10.04 crore in the March 2026 quarter
May 15,2026
Net Loss of Devyani International reported to Rs 10.04 crore in the quarter ended March 2026 as against net loss of Rs 14.74 crore during the previous quarter ended March 2025. Sales rose 18.50% to Rs 1436.86 crore in the quarter ended March 2026 as against Rs 1212.59 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 38.63 crore in the year ended March 2026 as against net profit of Rs 9.15 crore during the previous year ended March 2025. Sales rose 13.34% to Rs 5611.48 crore in the year ended March 2026 as against Rs 4951.05 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1436.861212.59 18 5611.484951.05 13
OPM %15.3315.32 -15.1316.37 -
PBDT164.35129.43 27 618.61582.66 6
PBT-18.13-22.35 19 -35.3712.79 PL
NP-10.04-14.74 32 -38.639.15 PL